Royce & Associates LP Chembio Diagnostics, Inc. Transaction History

Royce & Associates LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$0.66 - $1.23 $117,844 - $219,620	-178,553 Reduced 56.8%	135,800 $111,000
Q4 2021 Feb 07, 2022	SELL	$1.09 - $2.55 $193,039 - $451,604	-177,100 Reduced 36.04%	314,353 $358,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $304,675 - $550,831	-92,889 Reduced 15.9%	491,453 $2.39 Million
Q2 2020 Aug 07, 2020	SELL	$3.18 - $15.54 $1.88 Million - $9.18 Million	-590,974 Reduced 50.28%	584,342 $1.9 Million
Q1 2020 May 12, 2020	BUY	$2.36 - $5.6 $433,824 - $1.03 Million	183,824 Added 18.54%	1,175,316 $6.02 Million
Q4 2019 Feb 06, 2020	BUY	$3.94 - $5.76 $1.48 Million - $2.17 Million	375,874 Added 61.06%	991,492 $4.52 Million
Q3 2019 Nov 13, 2019	BUY	$4.84 - $7.25 $708,890 - $1.06 Million	146,465 Added 31.22%	615,618 $3.77 Million
Q4 2018 Feb 11, 2019	BUY	$4.95 - $10.5 $742,500 - $1.58 Million	150,000 Added 47.0%	469,153 $2.66 Million
Q3 2018 Nov 13, 2018	BUY	$9.2 - $11.5 $182,160 - $227,700	19,800 Added 6.61%	319,153 $3.35 Million
Q2 2018 Aug 09, 2018	BUY	$7.8 - $11.1 $655,200 - $932,400	84,000 Added 39.01%	299,353 $3.32 Million
Q1 2018 May 14, 2018	BUY	$7.05 - $9.0 $796,318 - $1.02 Million	112,953 Added 110.31%	215,353 $1.72 Million
Q4 2017 Feb 09, 2018	BUY	$5.95 - $8.35 $478,975 - $672,175	80,500 Added 367.58%	102,400 $840,000
Q2 2017 Aug 07, 2017	BUY	N/A	21,900	21,900 $132,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.